Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
TransMedics Group, Inc. - Common Stock
(NQ:
TMDX
)
115.06
-4.12 (-3.46%)
Streaming Delayed Price
Updated: 2:12 PM EST, Nov 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TransMedics Group, Inc. - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 01, 2022
Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.
Via
Benzinga
TransMedics Group: Q2 Earnings Insights
↗
August 01, 2022
TransMedics Group (NASDAQ:TMDX) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
4 Analysts Have This to Say About TransMedics Group
↗
July 26, 2022
Over the past 3 months, 4 analysts have published their opinion on TransMedics Group (NASDAQ:TMDX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
Analyst Ratings for TransMedics Group
↗
July 26, 2022
Over the past 3 months, 4 analysts have published their opinion on TransMedics Group (NASDAQ:TMDX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 30, 2022
Via
Benzinga
TransMedics Stock Skyrockets On Increased 2022 Guidance
↗
May 04, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
February 23, 2022
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Earnings Scheduled For August 1, 2022
↗
August 01, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
June 30, 2022
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!
Via
InvestorPlace
81 Biggest Movers From Yesterday
↗
May 05, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5%
↗
May 04, 2022
U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision.
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
↗
May 04, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
May 04, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 03, 2022
Gainers
Via
Benzinga
TransMedics Group: Q1 Earnings Insights
↗
May 03, 2022
TransMedics Group (NASDAQ:TMDX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings TransMedics Group reported...
Via
Benzinga
Earnings Outlook For TransMedics Group
↗
May 02, 2022
TransMedics Group (NASDAQ:TMDX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
TransMedics Receives FDA Premarket Approval for OCS™ DCD Heart Indication
↗
April 28, 2022
TransMedics Group, Inc. (NASDAQ: TMDX) received premarket approval (PMA) from U.S. Food and Drug Administration (FDA) for its OCS™ Heart System in favour of use with organs from donors after...
Via
Benzinga
Earnings Scheduled For May 3, 2022
↗
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 06, 2022
Gainers
Via
Benzinga
88 Biggest Movers From Yesterday
↗
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Surges 2%; South Jersey Industries Shares Spike Higher
↗
February 24, 2022
U.S. stocks pared some earlier losses toward the end trading, with the Nasdaq jumping 2% on Thursday. US President Biden, during his press briefing on Ukraine/Russia, said he...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
February 24, 2022
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...
Via
Benzinga
Mid-Day Market Update: Dow Drops Over 500 Points; Crude Oil Surges 6%
↗
February 24, 2022
U.S. stocks remained lower midway through trading on Thursday after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
↗
February 24, 2022
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
↗
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
Recap: TransMedics Group Q4 Earnings
↗
February 23, 2022
TransMedics Group (NASDAQ:TMDX) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:05 PM. Here's what investors need to know about the announcement....
Via
Benzinga
TransMedics Reports Positive Data From OCS DCD Heart Trial
↗
November 04, 2021
TransMedics Group Inc (NASDAQ: TMDX) has announced topline results from its OCS donors after circulatory death (DCD) Heart Trial. Related: TransMedics' OCS Heart...
Via
Benzinga
Earnings Scheduled For February 23, 2022
↗
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
↗
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
TransMedics' OCS Heart System Scores FDA Approval
↗
September 07, 2021
TransMedics Group Inc (NASDAQ: TMDX) has received FDA premarket approval (PMA) for its OCS Heart system. Related content: Benzinga's Full FDA...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.